Applying SigFuge to a cohort of lung SQCC samples, we identified CDKN2A, a tumor suppressor gene known to be highly altered in lung SQCC, and KLK12, a gene recently shown to have differential isoform usage in breast cancer. This evidence concerns the gene CDKN2A and breast cancer.